Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 97858
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.97858
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.97858
Characteristics | LILRB2 | ANGPTL2 | HLA-G | |||
High | Low | High | Low | High | Low | |
Age (years) | ||||||
≤ 60 | 18 (62.1) | 6 (35.3) | 14 (53.8) | 10 (50.0) | 16 (47.1) | 8 (66.7) |
> 60 | 11 (37.9) | 11 (64.7) | 12 (46.2) | 10 (50.0) | 18 (52.9) | 4 (33.3) |
Gender | ||||||
Male | 20 (69.0) | 13 (76.5) | 18 (69.2) | 15 (75.0) | 22 (64.7) | 11 (91.7) |
Female | 9 (31.0) | 4 (23.5) | 8 (30.8) | 5 (25.0) | 12 (35.3) | 1 (8.3) |
TNM stage | ||||||
I/II | 16 (55.2) | 9 (52.9) | 8 (30.8) | 17 (85.0)a | 17 (50.0) | 8 (66.7) |
III | 13 (44.8) | 8 (47.1) | 18 (69.2) | 3 (15.0) | 17 (50.0) | 4 (33.3) |
Tumor depth | ||||||
T1/2 | 11 (37.9) | 7 (41.2) | 7 (26.9) | 11 (55.0) | 13 (38.2) | 5 (41.7) |
T3 | 18 (62.1) | 10 (58.8) | 19 (73.1) | 9 (45.0) | 21 (61.8) | 7 (58.3) |
Lymph nodes metastases | ||||||
No | 10 (34.5) | 9 (52.9) | 3 (11.5) | 16 (80.0)a | 12 (35.3) | 7 (58.3) |
Yes | 19 (65.5) | 8 (47.1) | 23 (88.5) | 4 (20.0) | 22 (64.7) | 5 (41.7) |
Lauren typing | ||||||
Intestinal-type | 12 (41.4) | 6 (35.3) | 12 (46.2) | 6 (30.0) | 13 (38.2) | 5 (41.7) |
Diffuse-type | 9 (31.0) | 7 (41.2) | 7 (26.9) | 9 (45.0) | 12 (35.3) | 4 (33.3) |
Mixed-type | 8 (27.6) | 4 (23.5) | 7 (26.9) | 5 (25.0) | 9 (26.5) | 3 (25.0) |
LILRB2 | |||
High | Low | ||
ANGPTL2 | High | 19 (65.5) | 7 (41.2) |
Low | 10 (34.5) | 10 (58.8) | |
HLA-G | High | 24 (82.8) | 10 (58.8) |
Low | 5 (17.2) | 7 (41.2) |
- Citation: Wang L, Wu Q, Zhang ZW, Zhang H, Jin H, Zhou XL, Liu JY, Li D, Liu Y, Fan ZS. Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer. World J Gastrointest Oncol 2025; 17(2): 97858
- URL: https://www.wjgnet.com/1948-5204/full/v17/i2/97858.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.97858